EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL. (June 2017)

• Record Type: Journal Article
• Authors: Borchmann, P.; Goergen, H.; Kobe, C.; Eichenauer, D.; Greil, R.; Lohri, A.; Novak, U.; Markova, J.; Beck, H.; Meissner, J.; Zijlstra, J.M.; Ostermann, H.; Feuring‐Buske, M.; Dierlamm, J.; Eich, H.; Baues, C.; Rosenwald, A.; Fuchs, M.; Diehl, V.; Kuhnert, G.; Dietlein, M.; Engert, A.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 65
• Page End: 65
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2437_52
• Languages: English
• ISSNs: 0278-0232